Anticoagulation in COVID – 19: An Update

THERAPEUTIC CLASS

Anticoagulation in COVID – 19: An Update

Tiwari NR - Personal Name;

The novel coronavirus disease, 2019 (COVID – 19) evolved as an unprecedented pandemic. The severe acute respiratory
syndrome-corona virus-2 (SARS-CoV-2) infection has been associated with significantly deranged coagulation
parameters and increased incidence of thrombotic events. Deranged coagulation parameters, such as D-dimers
and fibrin degradation products, can indicate a poor prognosis, and their measurement will help stratify the patients
according to the disease severity, need of intensive care unit admission, and prediction of the clinical course

Availability

Location name is not set Location name is not set

REQJ4137-1

Available

Detail Information

Series Title: -
Call Number: -
Publisher: : .,
Collation: -
Language: English
ISBN/ISSN: -
Classification: NONE
Content Type: -
Media Type: -
Carrier Type: -
Edition: -
Subject(s): Cardiovascular & Hematopoeiteic System
Specific Detail Info: The Journal of Critical Care Medicine 2020;6(4):217-223
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

Read Here

Comments

You must be logged in to post a comment